Marshall Wace, LLP Moderna, Inc. Transaction History

Marshall Wace, LLP

$72.2 Billion
Q2 2024

A detailed history of Marshall Wace, LLP transactions in Moderna, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 35,200 shares of MRNA stock, worth $2.31 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

35,200

Previous 8,900 295.51%

Holding current value

$2.31 Million

Previous $948,000 340.93%

% of portfolio

0.01%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$101.21 - $166.61 $2.66 Million - $4.38 Million	26,300 Added 295.51%	35,200 $4.18 Million
Q1 2024 May 15, 2024	SELL	$85.37 - $115.44 $5.81 Million - $7.85 Million	-68,000 Reduced 88.43%	8,900 $948,000
Q4 2023 Feb 14, 2024	BUY	$69.51 - $104.43 $4.95 Million - $7.43 Million	71,142 Added 1235.53%	76,900 $7.65 Million
Q3 2023 Nov 14, 2023	SELL	$96.41 - $126.61 $312,561 - $410,469	-3,242 Reduced 36.02%	5,758 $594,000
Q2 2023 Aug 14, 2023	BUY	$118.5 - $160.53 $810,421 - $1.1 Million	6,839 Added 316.47%	9,000 $1.09 Million
Q1 2023 May 15, 2023	SELL	$135.66 - $197.02 $39 Million - $56.6 Million	-287,481 Reduced 99.25%	2,161 $331,000
Q4 2022 Feb 14, 2023	SELL	$118.38 - $210.04 $45.1 Million - $80 Million	-380,659 Reduced 56.79%	289,642 $52 Million
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $5.26 Million - $8.65 Million	44,546 Added 7.12%	670,301 $79.3 Million
Q2 2022 Aug 15, 2022	SELL	$117.13 - $176.59 $21.5 Million - $32.4 Million	-183,380 Reduced 22.66%	625,755 $89.4 Million
Q1 2022 May 16, 2022	BUY	$126.46 - $235.05 $96.5 Million - $179 Million	763,285 Added 1664.74%	809,135 $139 Million
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $9.67 Million - $15.8 Million	42,828 Added 1417.21%	45,850 $11.6 Million
Q3 2021 Nov 15, 2021	BUY	$221.9 - $484.47 $75,002 - $163,750	338 Added 12.59%	3,022 $1.16 Million
Q2 2021 Aug 13, 2021	SELL	$129.91 - $234.98 $8.77 Million - $15.9 Million	-67,483 Reduced 96.17%	2,684 $631,000
Q1 2021 May 17, 2021	SELL	$109.18 - $185.98 $19.9 Million - $33.9 Million	-182,117 Reduced 72.19%	70,167 $9.19 Million
Q4 2020 Feb 16, 2021	BUY	$65.74 - $169.86 $16.6 Million - $42.9 Million	252,284 New	252,284 $26.4 Million
Q3 2020 Nov 16, 2020	SELL	$54.34 - $94.85 $1.9 Million - $3.32 Million	-34,979 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$29.67 - $80.0 $1.04 Million - $2.8 Million	34,979 New	34,979 $2.25 Million
Q3 2019 Nov 14, 2019	SELL	$12.26 - $18.07 $1.4 Million - $2.07 Million	-114,512 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$13.7 - $28.34 $1.57 Million - $3.25 Million	114,512 New	114,512 $1.68 Million

Others Institutions Holding MRNA

# of Institutions

1,113

Shares Held

241M

Call Options Held

9.26M

Put Options Held

12.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Moderna, Inc. Transaction History